Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
92 Leser
Artikel bewerten:
(0)

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Nu Skin Enterprises, Inc. To Contact The Firm

NEW YORK, Jan. 25, 2014 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Nu Skin Enterprises, Inc. ("Nu Skin" or the "Company") (NYSE: NUS) of the March 24, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Nu Skin, and certain executives.

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO)

A complaint has been filed on behalf of all persons who purchased or otherwise acquired Nu Skin securities between October 25, 2011 and January 15, 2014, inclusive (the "Class Period") in the District of Utah.

The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.

Specifically, the action alleges that throughout the Class Period the Company and senior executives made a series of false and misleading statements concerning pyramid selling schemes the Company had engaged in in its Mainland China operations.

On January 15, 2014, a leading Chinese newspaper issued an investigative story suggesting that Nu Skin is an illegal pyramid scheme in China and utilizes unlawful and immoral business practices violating Chinese law. Following this news, the Company's stock declined an additional $21.24 per share, or over 15%, to close at $115.23 per share on January 15, 2014 on heavy volume.

Further, on January 16, 2014, the Company disclosed that Chinese government regulators were investigating its business practices.

Request more information now by clicking here: www.faruqilaw.com/NUSKIN. There is no cost or obligation to you.

Take Action

If you invested in Nu Skin stock, bonds or options between October 25, 2011 and January 15, 2014 and would like to discuss your legal rights, visit www.faruqilaw.com/NUSKIN. You can also contact us by calling Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com or fmcconville@faruqilaw.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Nu Skin's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Francis McConville, Esq.
fmcconville@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

SOURCE Faruqi & Faruqi, LLP

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.